Unnatural Products taps argenx’s help for ringed molecules, expands internal work into obesitynews2025-07-01T12:00:39+00:00July 1st, 2025|Endpoints News|
Sage plans to lay off almost every employee after reaching deal with Supernusnews2025-06-30T19:17:27+00:00June 30th, 2025|Endpoints News|
AbbVie bags Capstan’s in vivo CAR-T work with $2.1B buyout dealnews2025-06-30T12:36:58+00:00June 30th, 2025|Endpoints News|
Alphabet’s Calico inks $25M licensing deal for Mabwell’s IL-11 programsnews2025-06-27T11:08:00+00:00June 27th, 2025|Endpoints News|
A dinner in Paris revived talks for Sanofi’s $9.5B deal for Blueprintnews2025-06-27T09:09:43+00:00June 27th, 2025|Endpoints News|
Vor Bio bounces back with RemeGen autoimmune deal, $175M private placementnews2025-06-26T10:54:05+00:00June 26th, 2025|Endpoints News|
Novartis strikes cardiovascular discovery deal with Flagship’s ProFoundnews2025-06-26T10:30:41+00:00June 26th, 2025|Endpoints News|
Revolution secures up to $2B from Royalty Pharma in custom funding dealnews2025-06-24T15:23:27+00:00June 24th, 2025|Endpoints News|
Illumina to buy SomaLogic for $350M upfront, pushing further into proteomicsnews2025-06-23T11:05:17+00:00June 23rd, 2025|Endpoints News|
Humana details plans to grow its primary care clinicsnews2025-06-18T14:17:04+00:00June 18th, 2025|Endpoints News|
